19 results
DEFM14A
LABP
Landos Biopharma Inc
25 Apr 24
Proxy related to merger
5:07pm
recruitment efforts, study enrollment activities or clinical trial timelines, or (ii) terminate any ongoing clinical trials or activities for planned … , (B) amend or modify any existing clinical trial protocols, study recruitment efforts, study enrollment activities or clinical trial timelines, or (C
PREM14A
LABP
Landos Biopharma Inc
15 Apr 24
Preliminary proxy related to merger
5:18pm
product in development (i) amend or modify any existing clinical trial protocols, study recruitment efforts, study enrollment activities or clinical trial … , (A) initiate or commence any new clinical trials, (B) amend or modify any existing clinical trial protocols, study recruitment efforts, study enrollment
DEFA14A
LABP
Landos Biopharma Inc
25 Mar 24
Additional proxy soliciting materials
9:19am
, study recruitment efforts, study enrollment activities or clinical trial timelines, or (C) terminate any ongoing clinical trials or activities for planned
8-K
EX-2.1
LABP
Landos Biopharma Inc
25 Mar 24
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
8:54am
in development, (A) initiate or commence any new clinical trials, (B) amend or modify any existing clinical trial protocols, study recruitment efforts, study
8-K
EX-99.1
tgki1l4lzt
14 Sep 23
Collaboration Will Focus on Defining the Effects Of NX-13 in Ulcerative Colitis Patient Derived Organoid Models
8:11am
PRE 14A
p1dn20yjqbu412e cau
10 Apr 23
Preliminary proxy
4:20pm
DEF 14A
bx2j rdvhe2rbrtwc
28 Apr 22
Definitive proxy
4:16pm
10-K
k2zv1
31 Mar 21
Annual report
5:03pm
424B4
cwc1q 0rfwv
4 Feb 21
Prospectus supplement with pricing info
5:02pm
S-1/A
f8zv39
28 Jan 21
IPO registration (amended)
9:12am
S-1
8grm9w vpg
13 Jan 21
IPO registration
5:07pm
DRS/A
jnidp c2vr9ix5
1 Dec 20
Draft registration statement (amended)
12:00am
DRS/A
3zujd47q
1 Sep 20
Draft registration statement (amended)
12:00am
DRS
k84g2ergt6ndf
24 Jul 20
Draft registration statement
12:00am
- Prev
- 1
- Next